Healthcare entity
market-trends is the sole category represented across all 1 tracked stories. B Group, Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Healthcare story that mention Structure Therapeutics, all published on March 23, 2026.
Last mentioned: Mar 23, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
market-trends is the sole category represented across all 1 tracked stories. B Group, Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Healthcare story that mention Structure Therapeutics, all published on March 23, 2026. Each carries 2 original sources on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 14 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Structure Therapeutics. Shared-story counts are live from our verified record — not editorial picks.
Structure Therapeutics (GPCR) has experienced a 28% year-to-date decline in 2026, contrasting with its triple-digit gains over the previous year. Despite the recent sell-off, B Group, Inc. has initiated a $6.26 million position in the clinical-stage biotech, highlighting continued institutional interest in its oral GLP-1 pipeline.
Source: finance.yahoo.com · Jonathan Ponciano (us)
Structure Therapeutics is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
